Clinical Trial

A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-1）

Name: A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-1） — clinical trial record (NCT06930612)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a multi-center, randomized, double blind, placebo-controlled Phase II study to evaluate the efficacy and safety of CM512, and to observe the life quality of subjects, the Pharmacokinetics, Pharmacodynamics and immunogenicity of CM512 in patients with chronic rhinosinusitis with nasal polyposis (CRSwNP).

Trial Details

NCT Number	NCT06930612
Lead Sponsor	Keymed Biosciences Co.Ltd
Conditions	Chronic Rhinosinusitis With Nasal Polyposis
Enrollment	120 participants
Start Date	2025-05-16
Primary Completion	2026-09-16 (estimated)
Study Completion	2026-09-16 (estimated)
Updated on ClinicalTrials.gov	2025-04-16